Immediate Impact
1 from Science/Nature 51 standout
Citing Papers
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
2022 Standout
Works of Gian Antonio Da Prada being referenced
Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Gian Antonio Da Prada | 250 | 265 | 78 | 132 | 31 | 554 | |
| Zaid Abdel Rahman | 341 | 184 | 118 | 125 | 37 | 558 | |
| Carlo Zibera | 220 | 130 | 60 | 217 | 28 | 595 | |
| Nagaharu Tsukiji | 236 | 190 | 37 | 144 | 27 | 630 | |
| P Buchinger | 136 | 410 | 34 | 197 | 22 | 630 | |
| Leopold Öhler | 198 | 197 | 52 | 74 | 49 | 469 | |
| J. Graham Sharp | 248 | 253 | 81 | 113 | 26 | 626 | |
| A. Mario Marcondes | 125 | 252 | 152 | 163 | 23 | 555 | |
| Gabrilove Jl | 126 | 228 | 49 | 115 | 40 | 612 | |
| Claudine Graf | 201 | 121 | 51 | 216 | 25 | 526 | |
| J A Katzmann | 153 | 297 | 62 | 71 | 18 | 583 |
All Works
Loading papers...